Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion type Assertion NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_head.
- NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion description "[To determine the antitumor effect of arsenic trioxide (As2O3) on multidrug-resistant cells, we applied 3 human leukemia cell lines: daunorubicin (DNR)-resistant cell line K562/D1-9, which overexpresses p-glycoprotein (Pgp); DNR and 1-beta-D-arabinofuranosylcytosine (Ara-C) double-resistant cell line HL60/AD, which overexpresses multidrug resistance-associated protein (MRP1); and Bcl-2-transfected pre-B lineage leukemia cell line 697/Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_provenance.
- NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion evidence source_evidence_literature NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_provenance.
- NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion SIO_000772 15868938 NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_provenance.
- NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion wasDerivedFrom befree-2016 NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_provenance.
- NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_assertion wasGeneratedBy ECO_0000203 NP492937.RAReUms1zhIPR1j9g3EmbMs_uQ-8M1vcXgzxPdYVCrFBU130_provenance.